vs

Side-by-side financial comparison of CHEMUNG FINANCIAL CORP (CHMG) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.

CHEMUNG FINANCIAL CORP is the larger business by last-quarter revenue ($23.8M vs $14.5M, roughly 1.6× SS Innovations International, Inc.). CHEMUNG FINANCIAL CORP runs the higher net margin — 32.5% vs -17.0%, a 49.5% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs 20.3%). CHEMUNG FINANCIAL CORP produced more free cash flow last quarter ($43.8M vs $-3.2M). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 0.2%).

Chemung Canal Trust Company is a New York State chartered trust company based in Elmira, New York. It was founded as a publicly traded bank in 1833.

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

CHMG vs SSII — Head-to-Head

Bigger by revenue
CHMG
CHMG
1.6× larger
CHMG
$23.8M
$14.5M
SSII
Growing faster (revenue YoY)
SSII
SSII
+58.8% gap
SSII
79.1%
20.3%
CHMG
Higher net margin
CHMG
CHMG
49.5% more per $
CHMG
32.5%
-17.0%
SSII
More free cash flow
CHMG
CHMG
$47.0M more FCF
CHMG
$43.8M
$-3.2M
SSII
Faster 2-yr revenue CAGR
SSII
SSII
Annualised
SSII
99.9%
0.2%
CHMG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHMG
CHMG
SSII
SSII
Revenue
$23.8M
$14.5M
Net Profit
$7.7M
$-2.5M
Gross Margin
43.9%
Operating Margin
46.1%
-3.7%
Net Margin
32.5%
-17.0%
Revenue YoY
20.3%
79.1%
Net Profit YoY
30.9%
-28.5%
EPS (diluted)
$1.61
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHMG
CHMG
SSII
SSII
Q4 25
$23.8M
$14.5M
Q3 25
$28.8M
$12.8M
Q2 25
$10.1M
$10.0M
Q1 25
$25.7M
$5.1M
Q4 24
$25.9M
$8.1M
Q3 24
$24.3M
$4.4M
Q2 24
$23.4M
$4.5M
Q1 24
$23.7M
$3.6M
Net Profit
CHMG
CHMG
SSII
SSII
Q4 25
$7.7M
$-2.5M
Q3 25
$7.8M
$-3.7M
Q2 25
$-6.5M
$-256.7K
Q1 25
$6.0M
$-5.7M
Q4 24
$5.9M
$-1.9M
Q3 24
$5.7M
$-3.2M
Q2 24
$5.0M
$-4.1M
Q1 24
$7.0M
$-9.8M
Gross Margin
CHMG
CHMG
SSII
SSII
Q4 25
43.9%
Q3 25
48.1%
Q2 25
59.1%
Q1 25
21.2%
Q4 24
48.9%
Q3 24
52.8%
Q2 24
31.9%
Q1 24
20.0%
Operating Margin
CHMG
CHMG
SSII
SSII
Q4 25
46.1%
-3.7%
Q3 25
35.0%
-14.3%
Q2 25
-87.2%
1.0%
Q1 25
29.9%
-115.6%
Q4 24
29.0%
-22.7%
Q3 24
29.8%
-73.1%
Q2 24
26.8%
-90.9%
Q1 24
38.3%
-270.3%
Net Margin
CHMG
CHMG
SSII
SSII
Q4 25
32.5%
-17.0%
Q3 25
27.1%
-29.0%
Q2 25
-63.9%
-2.6%
Q1 25
23.4%
-111.0%
Q4 24
29.8%
-23.7%
Q3 24
23.5%
-74.0%
Q2 24
21.3%
-91.8%
Q1 24
29.7%
-270.5%
EPS (diluted)
CHMG
CHMG
SSII
SSII
Q4 25
$1.61
$-0.01
Q3 25
$1.62
$-0.02
Q2 25
$-1.35
$0.00
Q1 25
$1.26
$-0.03
Q4 24
$1.24
$-0.01
Q3 24
$1.19
$-0.02
Q2 24
$1.05
$-0.02
Q1 24
$1.48
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHMG
CHMG
SSII
SSII
Cash + ST InvestmentsLiquidity on hand
$50.1M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$254.7M
$38.2M
Total Assets
$2.7B
$74.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHMG
CHMG
SSII
SSII
Q4 25
$50.1M
$3.2M
Q3 25
$107.6M
$5.7M
Q2 25
$320.1M
$11.4M
Q1 25
$53.4M
$15.9M
Q4 24
$47.0M
$466.5K
Q3 24
$80.4M
$220.4K
Q2 24
$70.2M
$608.2K
Q1 24
$94.9M
$948.1K
Total Debt
CHMG
CHMG
SSII
SSII
Q4 25
Q3 25
Q2 25
$99.1M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CHMG
CHMG
SSII
SSII
Q4 25
$254.7M
$38.2M
Q3 25
$245.3M
$39.6M
Q2 25
$235.0M
$42.0M
Q1 25
$228.3M
$40.6M
Q4 24
$215.3M
$13.5M
Q3 24
$220.7M
$13.7M
Q2 24
$201.2M
$14.8M
Q1 24
$197.1M
$16.7M
Total Assets
CHMG
CHMG
SSII
SSII
Q4 25
$2.7B
$74.2M
Q3 25
$2.7B
$69.6M
Q2 25
$2.9B
$70.0M
Q1 25
$2.8B
$63.5M
Q4 24
$2.8B
$42.4M
Q3 24
$2.8B
$39.0M
Q2 24
$2.8B
$35.7M
Q1 24
$2.8B
$35.2M
Debt / Equity
CHMG
CHMG
SSII
SSII
Q4 25
Q3 25
Q2 25
0.42×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHMG
CHMG
SSII
SSII
Operating Cash FlowLast quarter
$45.5M
$-1.5M
Free Cash FlowOCF − Capex
$43.8M
$-3.2M
FCF MarginFCF / Revenue
183.7%
-22.3%
Capex IntensityCapex / Revenue
7.1%
11.8%
Cash ConversionOCF / Net Profit
5.88×
TTM Free Cash FlowTrailing 4 quarters
$71.9M
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHMG
CHMG
SSII
SSII
Q4 25
$45.5M
$-1.5M
Q3 25
$12.2M
$-7.5M
Q2 25
$9.7M
$-3.5M
Q1 25
$7.2M
$-6.1M
Q4 24
$29.8M
$-3.3M
Q3 24
$9.2M
$-2.5M
Q2 24
$6.5M
$-1.0M
Q1 24
$7.9M
$-2.7M
Free Cash Flow
CHMG
CHMG
SSII
SSII
Q4 25
$43.8M
$-3.2M
Q3 25
$11.8M
$-8.2M
Q2 25
$9.4M
$-3.8M
Q1 25
$6.9M
$-7.0M
Q4 24
$26.2M
$-3.4M
Q3 24
$8.6M
$-4.2M
Q2 24
$5.5M
$-3.1M
Q1 24
$7.9M
$-2.8M
FCF Margin
CHMG
CHMG
SSII
SSII
Q4 25
183.7%
-22.3%
Q3 25
41.1%
-64.1%
Q2 25
92.9%
-37.7%
Q1 25
26.7%
-136.2%
Q4 24
101.2%
-41.7%
Q3 24
35.2%
-96.9%
Q2 24
23.4%
-69.5%
Q1 24
33.1%
-76.9%
Capex Intensity
CHMG
CHMG
SSII
SSII
Q4 25
7.1%
11.8%
Q3 25
1.4%
5.9%
Q2 25
3.6%
3.2%
Q1 25
1.3%
17.0%
Q4 24
14.0%
1.5%
Q3 24
2.5%
38.8%
Q2 24
4.4%
46.8%
Q1 24
0.3%
3.5%
Cash Conversion
CHMG
CHMG
SSII
SSII
Q4 25
5.88×
Q3 25
1.57×
Q2 25
Q1 25
1.19×
Q4 24
5.04×
Q3 24
1.60×
Q2 24
1.30×
Q1 24
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHMG
CHMG

Segment breakdown not available.

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

Related Comparisons